Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding.
暂无分享,去创建一个
J. Holst | M. Bessler | W. Inabnet | J. Korner | C. Taveras
[1] S. Bloom,et al. Incretins and other peptides in the treatment of diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[2] M. Bessler,et al. Differential Effects of Gastric Bypass and Banding on Circulating Gut Hormone and Leptin Levels , 2006, Obesity.
[3] P. Butler,et al. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. , 2006, Diabetes care.
[4] A. Mari,et al. Mechanisms of Recovery From Type 2 Diabetes After Malabsorptive Bariatric Surgery , 2006, Diabetes.
[5] Josep Vidal,et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. , 2006, The Journal of clinical endocrinology and metabolism.
[6] P. Butler,et al. Comment to: Patti ME, Mcmahon G, Mun EC et al. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236–2240 , 2006, Diabetologia.
[7] R. Batterham,et al. Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters , 2006, Annals of surgery.
[8] J. Holst,et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia , 2005, Diabetologia.
[9] D. Cummings. Gastric bypass and nesidioblastosis--too much of a good thing for islets? , 2005, The New England journal of medicine.
[10] R. Lloyd,et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. , 2005, The New England journal of medicine.
[11] S. Aylwin. Gastrointestinal surgery and gut hormones , 2005 .
[12] S. Woods,et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. , 2005, American journal of physiology. Endocrinology and metabolism.
[13] M. Nauck,et al. GIP as a potential therapeutic agent? , 2004, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[14] Henry Buchwald,et al. Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.
[15] D. Cummings,et al. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.
[16] Yuichiro Yamada,et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity , 2002, Nature Medicine.
[17] D. Drucker,et al. Minireview: the glucagon-like peptides. , 2001, Endocrinology.
[18] J. Holst,et al. Tissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans , 1994, Diabetes.
[19] J. Holst,et al. Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy , 1991, Digestive Diseases and Sciences.
[20] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[21] J. Polak,et al. The effects of ileal transposition and jejunoileal bypass on food intake and GI hormone levels in rats , 1984, Physiology & Behavior.
[22] J. Holst,et al. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics. , 1983, The Journal of clinical endocrinology and metabolism.
[23] J. Holst. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. , 1982, The Biochemical journal.
[24] M. Bessler,et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. , 2005, The Journal of clinical endocrinology and metabolism.
[25] A. Andersen,et al. Plasma enteroglucagon after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio. , 1979, Scandinavian journal of gastroenterology.